| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |